Steven F Ethridge

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. pmc Performance of the Aptima HIV-1 RNA qualitative assay with 16- and 32-member specimen pools
    Steven F Ethridge
    Centers for Disease Control and Prevention, Division of HIV AIDS Prevention, 1600 Clifton Road, Mailstop E 46, Atlanta, GA 30333, USA
    J Clin Microbiol 48:3343-5. 2010
  2. doi request reprint Performance of an alternative laboratory-based algorithm for diagnosis of HIV infection utilizing a third generation immunoassay, a rapid HIV-1/HIV-2 differentiation test and a DNA or RNA-based nucleic acid amplification test in persons with established H
    Laura G Wesolowski
    Division of HIV AIDS Prevention, Centers for Disease Control and Prevention, 1600 Clifton Rd, NE MS E 46, Atlanta, GA 30333, USA
    J Clin Virol 52:S45-9. 2011
  3. pmc Repeat confirmatory testing for persons with discordant whole blood and oral fluid rapid HIV test results: findings from post marketing surveillance
    Laura G Wesolowski
    Division of HIV AIDS Prevention, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    PLoS ONE 3:e1524. 2008
  4. ncbi request reprint Costs and outcomes of laboratory diagnostic algorithms for the detection of HIV
    Angela B Hutchinson
    Centers for Disease Control and Prevention, Atlanta, GA, United States Electronic address
    J Clin Virol 58:e2-7. 2013
  5. ncbi request reprint Evaluation of supplemental testing with the Multispot HIV-1/HIV-2 Rapid Test and APTIMA HIV-1 RNA Qualitative Assay to resolve specimens with indeterminate or negative HIV-1 Western blots
    Laurie Linley
    Division of HIV AIDS Prevention, Centers for Disease Control and Prevention, United States Electronic address
    J Clin Virol 58:e108-12. 2013
  6. doi request reprint Comparative evaluation of Aptima HIV-1 Qualitative RNA assay performance using plasma and serum specimens from persons with established HIV-1 infection
    Steven F Ethridge
    Division of HIV AIDS Prevention, National Center for HIV, Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Rd MS E46, Atlanta, GA 30333, USA
    J Clin Virol 52:S63-6. 2011
  7. pmc HIV screening practices in U.S. hospitals, 2009-2010
    Andrew C Voetsch
    Centers for Disease Control and Prevention, Division of HIV AIDS Prevention, Atlanta, GA 30333, USA
    Public Health Rep 127:524-31. 2012
  8. doi request reprint Comparison of alternative interpretive criteria for the HIV-1 Western blot and results of the Multispot HIV-1/HIV-2 Rapid Test for classifying HIV-1 and HIV-2 infections
    Muazzam Nasrullah
    Division of HIV AIDS Prevention, National Center for HIV, Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, Mailstop E46, Atlanta, GA 30333, USA
    J Clin Virol 52:S23-7. 2011
  9. pmc Rapid human immunodeficiency virus test quality assurance practices and outcomes among testing sites affiliated with 17 public health departments
    Laura G Wesolowski
    Division of HIV AIDS Prevention, National Center for HIV AIDS, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Clin Microbiol 47:3333-5. 2009
  10. ncbi request reprint Post-marketing surveillance of OraQuick whole blood and oral fluid rapid HIV testing
    Laura G Wesolowski
    Division of HIV AIDS Prevention, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    AIDS 20:1661-6. 2006

Collaborators

Detail Information

Publications10

  1. pmc Performance of the Aptima HIV-1 RNA qualitative assay with 16- and 32-member specimen pools
    Steven F Ethridge
    Centers for Disease Control and Prevention, Division of HIV AIDS Prevention, 1600 Clifton Road, Mailstop E 46, Atlanta, GA 30333, USA
    J Clin Microbiol 48:3343-5. 2010
    ..The Aptima test can be used to screen for acute-phase HIV infection...
  2. doi request reprint Performance of an alternative laboratory-based algorithm for diagnosis of HIV infection utilizing a third generation immunoassay, a rapid HIV-1/HIV-2 differentiation test and a DNA or RNA-based nucleic acid amplification test in persons with established H
    Laura G Wesolowski
    Division of HIV AIDS Prevention, Centers for Disease Control and Prevention, 1600 Clifton Rd, NE MS E 46, Atlanta, GA 30333, USA
    J Clin Virol 52:S45-9. 2011
    ..An alternative diagnostic algorithm has been proposed to detect early HIV-1 infection and differentiate HIV-1 from HIV-2...
  3. pmc Repeat confirmatory testing for persons with discordant whole blood and oral fluid rapid HIV test results: findings from post marketing surveillance
    Laura G Wesolowski
    Division of HIV AIDS Prevention, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    PLoS ONE 3:e1524. 2008
    ..Previous reports have not described whether repeat testing adequately resolves the HIV-infection status of persons with discordant results...
  4. ncbi request reprint Costs and outcomes of laboratory diagnostic algorithms for the detection of HIV
    Angela B Hutchinson
    Centers for Disease Control and Prevention, Atlanta, GA, United States Electronic address
    J Clin Virol 58:e2-7. 2013
    ..While it promises greater sensitivity, it also raises concerns about costs...
  5. ncbi request reprint Evaluation of supplemental testing with the Multispot HIV-1/HIV-2 Rapid Test and APTIMA HIV-1 RNA Qualitative Assay to resolve specimens with indeterminate or negative HIV-1 Western blots
    Laurie Linley
    Division of HIV AIDS Prevention, Centers for Disease Control and Prevention, United States Electronic address
    J Clin Virol 58:e108-12. 2013
    ..The use of Western blot (WB) as a supplemental test after reactive sensitive initial assays can lead to inconclusive or misclassified HIV test results, delaying diagnosis...
  6. doi request reprint Comparative evaluation of Aptima HIV-1 Qualitative RNA assay performance using plasma and serum specimens from persons with established HIV-1 infection
    Steven F Ethridge
    Division of HIV AIDS Prevention, National Center for HIV, Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Rd MS E46, Atlanta, GA 30333, USA
    J Clin Virol 52:S63-6. 2011
    ....
  7. pmc HIV screening practices in U.S. hospitals, 2009-2010
    Andrew C Voetsch
    Centers for Disease Control and Prevention, Division of HIV AIDS Prevention, Atlanta, GA 30333, USA
    Public Health Rep 127:524-31. 2012
    ..In 2006, the Centers for Disease Control and Prevention (CDC) recommended HIV screening for all individuals 13-64 years of age in health-care settings. We determined the frequency of hospital adoption of these CDC recommendations...
  8. doi request reprint Comparison of alternative interpretive criteria for the HIV-1 Western blot and results of the Multispot HIV-1/HIV-2 Rapid Test for classifying HIV-1 and HIV-2 infections
    Muazzam Nasrullah
    Division of HIV AIDS Prevention, National Center for HIV, Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, Mailstop E46, Atlanta, GA 30333, USA
    J Clin Virol 52:S23-7. 2011
    ..HIV-1 and HIV-2 infections may be identified using assays designed to differentiate HIV-1 and HIV-2 antibody reactivity...
  9. pmc Rapid human immunodeficiency virus test quality assurance practices and outcomes among testing sites affiliated with 17 public health departments
    Laura G Wesolowski
    Division of HIV AIDS Prevention, National Center for HIV AIDS, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Clin Microbiol 47:3333-5. 2009
    ..Rapid tests (n = 86,749) were generally conducted according to manufacturers' instructions, but ongoing testing competency assessments and on-site QA monitoring were not uniformly conducted...
  10. ncbi request reprint Post-marketing surveillance of OraQuick whole blood and oral fluid rapid HIV testing
    Laura G Wesolowski
    Division of HIV AIDS Prevention, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    AIDS 20:1661-6. 2006
    ..Post-marketing surveillance was conducted to monitor the performance of the OraQuick Advance rapid HIV-1/2 antibody test (OraQuick) on whole blood and oral fluid...